Abstract
Acquired immune deficiency syndrome (AIDS) is a deadly disease that is the pathological consequence of infection with human immunodeficiency virus (HIV). The virus is spread via body fluids, and infection results in progressive immune dysfunction, most notably a loss of CD4+ cells, leading to a myriad of opportunistic infections and maladies. In spite of public education efforts that were expected to control the epidemic, the virus continues to spread, emphasizing that a means to battle the disease is mandatory. Despite extensive efforts by researchers around the world, an effective vaccine or chemotherapy drug has not been developed for preventing this deadly disease, nor is one expected in the foreseeable future. This failure of conventional methods indicates that more novel approaches need to be explored.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Vaishnav, Y. N. and Wong-Staal, F. (1991) The biochemistry of AIDS. Annu. Rev. Biochem. 60, 577–630.
Mulligan, R. C. (1993) The basic science of gene therapy. Science 260, 926–932.
Baltimore, D. (1988) Gene therapy intracellular immunization. Nature 335, 395–396.
Rossi, J., Elkins, D., Zaia, J., and Sullivan, S. (1992) Ribozymes as anti-HIV therapeutic agents: principles, applications and problems. AIDS Res. Hum. Retroviruses 8, 183–189.
Yu, M., Poeschla, E., and Wong-Staal, F. (1994) Progress toward gene therapy for HIV infection. Gene. Ther. 1, 13–26.
Hampel, A., Tritz, R., Hicks, M., and Cruz, P. (1990) Hairpin catalytic RNA model evidence for helices and sequence requirement for substrate RNA. Nucleic Acids Res. 18, 299–304.
Hampel, A., Nesbitt, S., Tritz, R., and Altschuler, M. (1993) The hairpin ribozyme, in Methods A Companion to Methods in Enzymology (Abelson, J. and Simon, M., eds.), American Press, San Diego, pp. 37–42.
Anderson, P., Monforte, J., Tritz, R., Nesbitt, S., Hearst, J., and Hampel, A. (1994) Mutagenesis of the hairpin ribozyme. Nucleic Acids Res. 22, 1096–1100.
Yu, M., Leavitt, M. C., Maruyama, M., Yamada, O., Young, D., Ho, A. D., and Wong-Staal, F. (1995) Intracellular immunization of human fetal cord blood stem/progenitor cells with a ribozyme against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 92, 699–703.
Leavitt, M. C., Yu, M., Yamada, O., Kraus, G., Looney, D., Poeschla, E., and Wong-Staal, F. (1994) Transfer of an anti-HIV-1 ribozyme gene into primary human lymphocytes. Hum. Gene. Ther. 5, 1115–1120.
Rossi, J. J. and Sarver, N. (1992) Catalytic antisense RNA (ribozymes) their potential and use as an anti-HIV-1 therapeutic agents. Adv. Exp. Med. Biol. 312, 95–109.
Yamada, O., Kraus, G., Leavitt, M. C., Yu, M., and Wong-Staal, F. (1994) Activity and cleavage site specificity of an anti-HIV hairpin ribozyme in human T cells. Virology 205, 121–126.
Yu, M., Poeschla, E., Yamada, O., Degrandis, P., Leavitt, M. C., Heusch, M., Yee, J.-K., Wong-Staal, F., and Hampel, A. (1995) In vitro and n vivo characterization of a second functional hairpin ribozyme against HIV-1. Virology 206, 381–386.
Yu, M., Ojwang, J., Yamada, O., Hampel, A., Rappaport, J., Looney, D., and Wong-Staal, F. (1993) A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90, 6340–6344.
Holland, J. J., Spindler, K., Horodyski, F., Grabau, E., Nichol, S., and VandePol, S. (1982) Rapid evolution of RNA genomes. Science 215, 1577–1585.
Duarte, E. A., Novella, I. S., Weaver, S. C., Domingo, E., Wain-Hobson, S., Clarke, D. K., Moya, A., Elena, S. F., de la Torre, J. C., and Holland, J. J. (1994) RNA virus quasispecies significance for viral disease and epidemiology. Infect. Agents and Dis. 3, 201–214.
Preston, B. D., Potesz, B. J., and Loeb, L. A. (1988) Fidelity of HIV-1 reverse transcriptase. Science 242, 1168–1171.
Roberts, J. D., Bebenek, K., and Kunkel, T. A. (1988) The accuracy of reverse transcriptase from HIV-1. Science 242, 1171–1173.
Yamada, O., Yu, M., Yee, J.-K., Kraus, G., Looney, D., and Wong-Staal, F. (1994) Intracellular immunization of human T cells with a hairpin ribozyme against human immunodeficiency virus type 1. Gene. Ther. 1, 38–45.
Miller, A. D. (1992) Retroviral Vectors. Curr. Top Microbiol. Immunol. 158, 1–24.
Muzyczka, N. (1992) Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr. Top Microbiol. Immunol. 158, 97–129.
Nienhius, A. W., McDonagh, K. T., and Bodine, D. M. (1991) Gene transfer into hematopoietic cells. Cancer 67, 2700–2704.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Humana Press Inc.
About this protocol
Cite this protocol
Duarte, E.A., Leavitt, M.C., Yamada, O., Yu, M. (1997). Hairpin Ribozyme Gene Therapy for AIDS. In: Turner, P.C. (eds) Ribozyme Protocols. Methods in Molecular Biology™, vol 74. Humana Press. https://doi.org/10.1385/0-89603-389-9:459
Download citation
DOI: https://doi.org/10.1385/0-89603-389-9:459
Publisher Name: Humana Press
Print ISBN: 978-0-89603-389-4
Online ISBN: 978-1-59259-560-0
eBook Packages: Springer Protocols